미국의 약국 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 소유 형태별, 국가별 및 부문별 예측(2026-2033년)

U.S. Pharmacy Market Summary

The U.S. pharmacy market size was valued at USD 801.6 billion in 2025 and is projected to grow from USD 878.1 billion in 2026 to USD 1707.0 billion by 2033, at a CAGR of 10.0% from 2026 to 2033. The growth is attributed to the rising prevalence of chronic diseases, the high utilization of prescription drugs, and the increasing elderly population in the country.

A report published in January 2024 by American Heart Association (AHA) highlights a significant awareness gap surrounding cardiovascular health in the U.S. Despite heart disease remaining the country's leading cause of death for more than 100 years, 51% of surveyed U.S. adults did not identify it as the leading cause of death, while 18% incorrectly identified cancer as the leading cause. This lack of awareness is particularly concerning because cardiovascular disease affects 48.6% of the U.S. population, and 46.7% of adults have high blood pressure, with 38% of those individuals unaware of their condition.

The section below outlines the key factors driving the growth of the U.S. market for pharmacy, highlighting the rising prevalence of chronic diseases and the increasing need for prescription medications and long-term medication management. It also examines the growing adoption of specialty drugs and high-cost therapies, the expansion of pharmacy-based healthcare services such as vaccinations, chronic disease management, and medication counseling, and the increasing integration of digital technologies, ePharmacies, mail-order services, and tele-pharmacy.

U.S. Pharmacy Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pharmacy market report based on type, product, and ownership.

• Type Outlook (Revenue, USD Billion, 2021 - 2033)
• Retail chains (e.g., Walgreens, CVS)
  • Supermarket pharmacies
  • Health system / hospital pharmacies
  • Independent pharmacies
  • Mail-order pharmacies
  • Specialty / central fill pharmacies
  • Long-term care and defense-related pharmacies
  • ePharmacy
  • Others
• Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Prescription
  • OTC
• Ownership Outlook (Revenue, USD Billion, 2021 - 2033)
  • Chain
  • Independent
• Country Outlook (Revenue, USD Billion, 2021 - 2033)
  • Southeast
  • Southwest
  • West
  • Midwest
  • Northeast

Table of Contents

Chapter 1. Report Scope & Research Methodology

• 1.1 Market Segmentation
  • 1.1.1 Segment Definition
    • 1.1.1.1 Product
    • 1.1.1.2 Type
    • 1.1.1.3 Ownership
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
  • 1.3.2 Purchased Database
  • 1.3.3 GVR's Internal Database
  • 1.3.4 Secondary Sources
  • 1.3.5 Primary Research
  • 1.3.6 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Three Pillars of Market Estimation
    • 1.6.1.1 Secondary Market Research
    • 1.6.1.2 Primary Market Intelligence
      • 1.6.1.2.1 In-Depth Interviews (IDIs)
      • 1.6.1.2.2 Online Survey Program
  • 1.6.2 Market Modeling & Forecasting
    • 1.6.2.1 Model 1: Volume-Price Analysis
      • 1.6.2.1.1 Step 1: Prescription volume estimation
      • 1.6.2.1.2 Channel-Wise Methodology
        • 1.6.2.1.2.1 Retail Chains (CVS, Walgreens, etc.)
        • 1.6.2.1.2.2 Supermarket Pharmacies (Kroger, Albertsons, Publix)
        • 1.6.2.1.2.3 Health System / Hospital Outpatient Pharmacies
        • 1.6.2.1.2.4 Independent Pharmacies
        • 1.6.2.1.2.5 Mail-Order Pharmacies
        • 1.6.2.1.2.6 Specialty / Central Fill Pharmacies
        • 1.6.2.1.2.7 Long-Term Care (LTC) and Defense-Related Pharmacies
        • 1.6.2.1.2.8 ePharmacies (Amazon, Capsule, Hims & Hers, etc.)
        • 1.6.2.1.2.9 Other Channels
        • 1.6.2.1.2.10 Aggregation & Triangulation
      • 1.6.2.1.3 Step 2: Determining Average Realized Price (ARP)
      • 1.6.2.1.4 Step 2: OTC Revenue
    • 1.6.2.2 Model 2: Company Market Share Analysis
      • 1.6.2.2.1 Step 1: Public Filings
      • 1.6.2.2.2 Step 2: Private & Independent Estimates
      • 1.6.2.2.3 Step 3: Market Share Allocation
    • 1.6.2.3 CAGR/Forecasting Calculations & Assumptions
      • 1.6.2.3.1 Key Forecasting Drivers and Weights
      • 1.6.2.3.2 Scenario Framework (2026 - 2033)
      • 1.6.2.3.3 Factor-Based Impact Assessment
  • 1.6.3 Estimation Process: Pharmacy Split By Catchment Area
    • 1.6.3.1 Data Sources
    • 1.6.3.2 Estimation Process
  • 1.6.4 Estimation Process: Pharmacy Split By Product Form
  • 1.6.5 Company-Level Metric's Estimation
    • 1.6.5.1 Financial Performance
      • 1.6.5.1.1 2025 Revenue & EBITDA (Pharmacy-Only)
      • 1.6.5.1.2 5-Year Forecast of Revenue & EBITDA
      • 1.6.5.1.3 Balance Sheet Health Indicators
    • 1.6.5.2 Volumes & Operations
      • 1.6.5.2.1 2025 Total Prescriptions; 5-Year Rx Forecast
      • 1.6.5.2.2 % Fulfilled via Central Fill; Volumes Split by Catchment Area
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Research Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2. Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook - I
• 2.3 Segment Outlook- II
• 2.4 Competitive Scenario

Chapter 3. U.S. Pharmacy Market - Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Related Market Outlook
    • 3.1.2.1 U.S. pharmacy benefit management market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Expanding health insurance coverage
    • 3.2.1.4 Increasing demand for specialty drugs
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Product recalls and lawsuits
    • 3.2.2.2 Lack of trained staff
  • 3.2.3 Market Opportunity Analysis
  • 3.2.4 Market Challange Analysis
• 3.3 Regulatory Scenario & Reimbursement Outlook
  • 3.3.1 Regulatory Scenario
  • 3.3.2 Reimbursement Scenario
• 3.4 Business Environment Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
  • 3.4.2 Pestle Analysis

Chapter 4. U.S. Pharmacy Market: Product Estimates & Trend Analysis

• 4.1 U.S. Pharmacy Market: Product Segment Dashboard
• 4.2 Product Movement & Market Share Analysis, 2025 & 2033
• 4.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Product (USD Billion)
  • 4.3.1 Prescription
    • 4.3.1.1 Prescription market, 2021 - 2033 (USD Billion)
  • 4.3.2 Over-the-Counter (OTC)
    • 4.3.2.1 OTC market, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Pharmacy Market: Type Estimates & Trend Analysis

• 5.1 U.S. Pharmacy Market: Type Segment Dashboard
• 5.2 Type Movement & Market Share Analysis, 2025 & 2033
• 5.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Type, 2021 - 2033 (USD Billion)
• 5.4 U.S. Pharmacy Market: Estimated Number of Pharmacies, By Type, 2021 - 2033 (Unit)
• 5.5 U.S. Pharmacy Market: Estimated Prescription Volume, By Type, 2021 - 2033 (Million)
• 5.6 U.S. Pharmacy Market: Estimated Prescription Volume, By Catchment Area, 2025 (%)
• 5.7 U.S. Pharmacy Market: Estimated Prescription Volume, By Filled Prescriptions (TRx), 2025 (%)
  • 5.7.1 Retail Chains
    • 5.7.1.1 Retail chains market, 2021 - 2033 (USD Billion)
  • 5.7.2 Supermarket Pharmacies
    • 5.7.2.1 Supermarket pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.3 Health System / Hospital Pharmacy
    • 5.7.3.1 Health system / Hospital pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.4 Independent Pharmacies
    • 5.7.4.1 Independent pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.5 Mail-Order Pharmacies
    • 5.7.5.1 Mail-order pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.6 Specialty / Central Fill Pharmacies
    • 5.7.6.1 Specialty / central fill pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.7 Long-Term Care And Defense-Related Pharmacies
    • 5.7.7.1 Long-term care and defense-related pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.8 Epharmacy
    • 5.7.8.1 ePharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.9 Others
    • 5.7.9.1 Others market, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Pharmacy Market: Ownership Estimates & Trend Analysis

• 6.1 U.S. Pharmacy Market: Ownership Segment Dashboard
• 6.2 Ownership Movement & Market Share Analysis, 2026 & 2033
• 6.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Ownership, 2021 - 2033 (USD Billion)
  • 6.3.1 Chains
    • 6.3.1.1 Chains market, 2021 - 2033 (USD Billion)
  • 6.3.2 Independent
    • 6.3.2.1 Independent market, 2021 - 2033 (USD Billion)